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Abstract Vaginal practices may interfere with the use
and/or the effectiveness of female-initiated prevention
methods. We investigated whether vaginal practices dif-
fered by randomization group in a phase III trial of the
diaphragm with lubricant gel (MIRA) in Sub-Saharan
Africa (n = 4925), and if they were associated with con-
sistent use of study methods. At baseline, vaginal practices
were commonly reported: vaginal washing (82.77%),
wiping (56.47%) and insertion of dry or absorbent mate-
rials (20.58%). All three practices decreased during the
trial. However, women in the intervention group were
signiﬁcantly more likely to report washing or wiping dur-
ing follow-up compared to those in the control group.
Additionally, washing, wiping, and insertion, were all
independently and inversely associated with consistent
diaphragm and gel use and with condom use as well,
regardless of study arm. A better understanding of the
socio-cultural context in which these practices are
embedded could improve educational strategies to address
these potentially modiﬁable behaviors, and may beneﬁt
future HIV prevention interventions of vaginal methods.
Keywords Vaginal practices  HIV prevention trials 
Female-initiated methods  Condoms  Africa
Introduction
In Sub-Saharan Africa, vaginal practices are widespread
with prevalence reportedly ranging from 6 to 98% [1].
They are conducted for a variety of reasons including, but
not limited to, genital hygiene, sexuality (sex preparation
or sexual enhancement), and vaginal health/treatment of
genital symptoms [2–4]. Women’s genital hygiene is
highly valued and there are clear norms regarding lubri-
cation during sex, vaginal cleanliness and related vaginal
practices. Speciﬁcally, the natural state of the vagina is
expected to be dry and tight, with the interrelated positive
sensations of cleanliness and warmth/heat generated by
friction during sex. Consequently, women in this area are
concerned with excessive wetness or lubrication, which
may indicate disease, ‘‘dirt’’ in the vagina or a ‘‘loose’’
sexuality [4–7]. To maintain the desired vaginal state, a
range of practices are used, including intravaginal cleans-
ing and insertion of substances [4]. The most common
substances used during vaginal practices are water, soap,
commercial detergents, lemon or vinegar as well as tradi-
tional preparations with herbs or other dry materials such
as cloth, paper or cotton wool [8, 9].
Given the high prevalence of vaginal practices in Sub-
Saharan Africa, it is essential to understand whether these
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of chemical or physical barrier methods that are currently
being evaluated for their effectiveness in preventing HIV
infection [3]. Female-initiated methods, such as microbi-
cides and diaphragms, require vaginal insertion of a device
or application of gel through a delivery system (single dose
or reusable applicator, ring, diaphragm or other cervical
barriers) [10–12]. While experience with vaginal practices
may facilitate ease and comfort with inserting or removing
these investigational vaginal methods, such habits, partic-
ularly if they occur for sex preparation and around the time
of sex, could interfere with willingness to use and correct
use of these methods (especially if such methods are coi-
tally dependent), as well as their biological efﬁcacy. The
protocols for HIV prevention trials of female-initiated
methods have often requested that participants abstain from
vaginal practices, but it is not clear whether these guide-
lines have been followed [7, 13, 14].
To examine the relationship between vaginal practices
and provision and use of female-initiated methods, we
analyzed data from the MIRA study, an open-label multi-
site randomized controlled trial to assess the effectiveness
of the diaphragm used with lubricant gel for the prevention
of HIV/STI acquisition in HIV-negative women recruited
from the general population in Southern Africa [15]. We
previously reported that the diaphragm and gel had high
acceptability among participants [16]. However, diaphragm
adherence was sub-optimal and condom use was differen-
tial between study arms. [17, 18]. Continuing our exam-
inations of factors inﬂuencing study methods use in MIRA,
here, we investigated whether vaginal practices inﬂuenced
use, whether practices changed during the trial, and if they
differed between women randomized to the intervention
(who received a diaphragm, vaginal gel and condoms), as
compared to those in the control arm (who received male
condoms only).
Methods
The MIRA trial was conducted in Harare, Zimbabwe,
Durban and Johannesburg, South Africa, between 2003 and
2006 and included a total of 5,039 participants. Retention
rate was high (93%) and was similar between study ran-
domization groups [15]. Women were followed quarterly
for 12–24 months, depending on their calendar date of
enrolment, with a median of 21 months follow-up or 7
quarterly visits (range 0–8 quarterly visits). The study
protocol was reviewed and approved by all participating
institutions’ ethical review boards (www.ClinicalTrials.gov,
NCT00121459); detailed trial procedures and primary
results have been published elsewhere [15].
MIRA Trial Participants
Women were recruited from the general community and
health facilities that provided services to women. Key
eligibility criteria included being: sexually active; between
18 and 49 years; HIV negative; STI negative for cervical
and vaginal STIs (or treatment thereof); with a healthy
cervix, able to demonstrate the ability to correctly insert the
diaphragm prior to randomization, and able to provide
informed consent for participation.
Study Procedures
At the enrolment visit, all women received diaphragm
education and demonstration using a pelvic model, and
were ﬁtted with a diaphragm by a trained clinician and
practiced diaphragm insertion at the clinic as described
previously [17]. Women completed a baseline Audio
Computer Assisted Self-interviewing (ACASI) question-
naire (in local language) on: demographics, sexual behav-
ior, vaginal practices, as well as current and previous use of
the diaphragm, gel, and condoms. Eligible consenting
women were then randomly assigned to intervention or
control groups [15]. Because the intervention was not
blinded, treatment assignment was known to the participant
and clinical team (but not to the investigators and analysis
team). At each quarterly follow-up visit, women completed
an ACASI, and received: a clinical exam if indicated,
product adherence and risk reduction counseling and a
resupply of male condoms, as well as study gel (in the
intervention group only). Use of effective contraception
was encouraged and hormonal contraceptives were pro-
vided at no cost to all participants.
Intervention and Product Counseling
In the intervention group, women received a latex dia-
phragm (All_Flex Arcing Spring diaphragm: Ortho-
McNeil Pharmaceutical, Raritan, NJ), a supply of non-
contraceptive lubricant gel (Replens
, Lil Drug Store
Products, Cedar Rapids, IA) and male condoms. Women
randomized to the control group received male condoms
only. Participants in both groups received a comprehensive
HIV prevention package including HIV/STI pre-and post-
test counseling, treatment of curable laboratory-diagnosed
STIs, condom promotion, and intensive risk reduction
counseling.
Women in the intervention group were counseled to
insert the diaphragm into the vagina any time convenient to
them prior sexual intercourse, and to leave it in for 6 h post
coitus. We counseled women to use the diaphragm with the
lubricant gel by emptying an applicator of gel (2.5 g) into
the dome of the diaphragm and spreading it onto the rim
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123before application; additionally, women were asked to
insert another applicator of gel in the vagina before each
act of vaginal sex. At each visit, women were provided
with a 3-month supply of the gel and could return to the
clinic for more if desired. Because the effect of the dia-
phragm on HIV/STI prevention was unknown, all women
were counseled to use condoms for every sexual act. The
diaphragm is approved for contraception only when used
with a spermicide [19], so participants were told not to use
the diaphragm and lubricant gel for contraception. As part
of study counseling, all participants were also discouraged
from continuing any vaginal practices during the trial.
Women were advised that they could only wash outer-
genitalia after sex with water or water and soap. Further-
more, women in the intervention group were speciﬁcally
instructed not to clean the vagina or insert other vaginal
products after they had inserted the diaphragm and gel, and
before sex took place. Women, who nevertheless chose to
continue vaginal practices, were encouraged to report and
document them at follow-up visits.
Measures
Vaginal practices were assessed by ACASI at enrolment
(and at quarterly follow-up visits) by asking participants
the following three questions (ﬁve response categories:
never to once per day or more, dichotomized for this
analysis into Ever versus Never): Washing: ‘‘During the
last 3 months (since your last computerized interview),
how often did you wash inside your vagina?’’, Wiping:
‘‘During the last 3 months (since your last computerized
interview), how often did you wipe, using dry cloth, paper,
or cotton wool, inside your vagina?’’, Inserting: ‘‘During
the last 3 months (since your last computerized interview),
how often did you insert paper, tampon, cloth, or cotton
wool into your vagina and leave it in for several hours or
all day? (This does NOT include when you may have been
menstruating.)’’
Additionally, using ACASI, we also assessed the spe-
ciﬁc products used during these practices by women at two
time points: baseline, and their last study visit. Women
reported which speciﬁc product(s) they had used from the
following list: water (only), soap and water, and ‘‘other
products’’ which combines reported use of vinegar, com-
mercial lubricant (such as KY jelly, Vaseline, or other),
douche, natural agents (such as herbs, pulverized rock,
mud, lemon, lemon juice, or other), commercial cleaning
product (dettol, betadine, detergent, disinfectant, potassium
permanganate, or other), or unspeciﬁed other products.
Study methods use: Among sexually active participants,
we considered the following measures of study methods
use assessed by ACASI at every quarterly visit: ‘‘Since
your last visit, how often have you used a diaphragm when
having sex?’’ (never, B 50%, [50%, always). Women
were asked the same questions about gel use and about
male condom use. For each time interval between two
quarterly visits, women who reported always using the
diaphragm and always using gel since their last visit, were
classiﬁed as ‘‘consistent diaphragm and gel users’’ for that
time interval; our primary outcome measure. We also
created a dichotomous measure of consistent condom use
(‘‘always’’ used male condoms versus less than always) for
each time interval.
We examined the following baseline variables (gathered
through in-person interview or ACASI) as potential con-
founders in the multivariable models (described below).
These were selected a priori, based on the literature and
from prior published analyses of MIRA [15, 17, 20]: study
site, age, education, cohabitation, marital status; having a
positive test for any curable STI (Chlamydia, gonorrhea,
trichomoniasis, syphilis), indicator variables both for par-
ticipant’s high-risk behavior and for having a high-risk
partner (see Table 1 for deﬁnitions), and randomization
group (for the full sample analyses).
Statistical Analyses
Our ﬁnal analytic sample included 4,925 (97.73%) of the
total MIRA participants, who had at least one follow-up
visit and responded to the quarterly vaginal practice
questions of washing, wiping and insertion. Because of
variations in vaginal practices and in consistent method use
by study sites, all analyses described below were controlled
for study site.
Vaginal Practices Trends
Preliminary analyses focused on tabulation of observed
frequencies of various vaginal practices at each visit,
overall, and by study randomization group. All compari-
sons were performed using GEE logistic regression to
model a repeatedly measured binary outcome of whether a
vaginal practice was reported by the participant. We
compared speciﬁc vaginal practices at baseline and follow-
up between the two study groups. We assessed change in
vaginal practices over the follow-up period and included a
visit by study group interaction term in these models to
determine whether change in vaginal practices over the
follow-up period differed by study group.
Relationship Between Vaginal Practices and Use
of Study Methods
The associations between speciﬁc vaginal practices (a) at
baseline and (b) at follow-up and our main method use
outcome (consistent use of diaphragm/gel during follow-
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in univariate and multivariate models, using GEE logistic
regression. We ﬁrst examined separately each vaginal
practice assessed either at baseline or at follow-up, for its
association with the outcome. Although at baseline, the
three vaginal practices were moderately correlated with
each other (assessed by Pearson correlation coefﬁcients,
data not shown), there was no co linearity between them
(assessed by the Variation Inﬂation Factor (VIF) values of
approximately 1). Similarly, VIF values suggested no co
linearity among the three vaginal practices at follow-up.
Consequently, all three baseline and time-dependent
exposure variables of washing, wiping and insertion were
entered in one multivariate model. Next, potential baseline
Table 1 Baseline socio-demographic characteristics, reproductive history and sexual behavior of MIRA participants
Category Total (n = 4925) Total (%)
Age (#)
24-year-old or younger 1878 38.14
25–34-year-old 1936 39.32
35-year-old or older 1110 22.54
At least high school education
a 2165 43.99
One lifetime partner (versus 2–30) 2520 51.17
Married 2917 59.23
Living together 3342 67.86
Coital frequency (per week)
Three times or fewer 3220 65.38
[3 times 1705 34.62
Exchanged sex in past 3 months 381 7.74
Tested positive for STI(s)
b 564 11.45
High behavior risk (at least one indicator versus none)
c 1406 28.55
High partner risk (at least one indicator vs. none)d,e 3368 68.40
Ever used a diaphragm 3 0.06
Frequency of condom use in past 3 months (enrollment)
Never 1463 29.71
Sometimes 1926 39.11
Always 1536 31.19
Current contraceptive use (screening)
Long term
f 297 6.07
Injectable hormones 1217 24.71
Pill
g 1786 36.26
Barrier
h 997 20.24
Other/none 628 12.75
Study site
Harare 2450 49.75
Durban 1471 29.87
Johannesburg 1004 20.39
a 3 observations missing
b At least one positive test for CT, GC, TV or Syphilis at screening or enrollment
c Indicators include: any exchange of sex for money/food/drugs/shelter, two or more sexual partners within last 3 months, ever had vaginal sex
under inﬂuence of drugs/alcohol in last 3 months, ever used needle for injectable drug use, ever had anal sex
d Indicators include: having any sexual partners test positive for HIV, suspect or know that regular partner had other sex partners in the last
3 months, ever had vaginal sex when partner was under inﬂuence of drugs/alcohol in last 3 months, regular partner was away from home -
C1 months. Contraceptive methods are hierarchically coded by most effective methods
e 1 observation missing
f Long term methods include tubal ligation, vasectomy, IUD, and implants such as Jadelle & Norplant
g Pill methods include combined oral contraceptive and progesterone only pills
h Barrier methods include male or female condoms
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123confounders of the association between vaginal practices
and consistent use of study methods were examined. We
selected variables that were signiﬁcantly associated at the
univariate level with the outcome. The ﬁnal multivariate
models only included predictors of interests and con-
founders that were signiﬁcant at the P\0.05 level. Two
hundred ninety-nine women HIV-seroconverted during the
trial, and they were censored after their seroconversion visit
because we hypothesized that this event would change their
vaginal practices, sexual behavior and study method use.
Identical steps were used for the analyses of vaginal
practices and consistent condom use during follow-up. In
this case, we combined the two study groups (intervention
and control) and adjusted for study group (and study site)
as group assignment was not found to be an effect modiﬁer
of the vaginal practice and condom use relationship. All
analyses were conducted using SAS version 9.1 (SAS
Institute, Inc., Cary, NC, USA).
Results
Study Sample Description and Vaginal Practices
Our study included 4,925 MIRA participants with the fol-
lowing baseline characteristics (see Table 1): over one-
third were 18–24-year-old; over half had only one lifetime
partner, 59% were married and 44% had at least a high
school education. Half the sample was from Harare, 30%
from Durban and 20% from Johannesburg. While 31% of
women reported ‘‘always’’ using condoms in the past
3 months at their enrolment visit, only three women
reported ever using a diaphragm.
As shown in Table 2, vaginal practices were prevalent:
at baseline, most women (82.8%) reported washing in-
travaginally in the previous 3 months (61.4% reported this
practice once a day or more). A subset of participants was
asked during the ﬁrst year of the trial what they used to
wash their vagina. Of the 1,825 women who were asked
this question, 72.9% reported using their ﬁnger, 27.8%
reported using cloth and 4.7% other types of applicators
(data not shown in table). Wiping intravaginally in the
previous 3 months was reported by 56.5% of women
(40.6% reported wiping once a day or more) and 20.6%
reported inserting dry or absorbent materials in their vagina
(e.g. paper, tampon, cloth, or cotton wool) and leaving it
for several hours in the previous 3 months (13.0% reported
insertion once a day or more). Few women (12.6%)
reported no practices, 31.8% reported one practice, and
56.6% reported C2 practices. At baseline, there were no
differences by randomization group in the three vaginal
practices examined: washing, wiping, and insertion
(Table 2). However, there were signiﬁcant differences in
the baseline prevalence of practices among the three study
sites (data not shown in tables): washing was highest in
Johannesburg (86.7 vs. 77.9% in Durban and 84.1% in
Harare, Chi-square P\0.0001), Zimbabwean women
reported more frequent wiping (68.0 vs. 40.9% in Durban
and 51.3% in Johannesburg, Chi-square P\0.0001) and
insertion (25.6 vs. 12.9% in Durban and 19.4% in Johan-
nesburg, Chi-square P\0.0001).
Speciﬁc product use was reported by more than half the
baseline sample, and was balanced between randomization
groups as well (Table 2). Use of soap and water was
reported by a third of women, 29.2% used water alone, and
only about 5% reported use of any other products. Durban
reported the highest frequency of using products intra-
vaginally (64.6 vs. 55.8% in Johannesburg and 44.9% in
Harare, Chi-square P\0.0001). Given that water or water
and soap were mentioned most frequently, expectedly,
speciﬁc product use was most correlated with washing
(r = 0.20, P\0.0001) and less so with wiping (r = 0.06,
P\0.0001) and insertion (r = 0.07, P\0.0001).
Vaginal Practices During Follow-Up and by Study
Group
As shown in Table 2, during follow-up, there was a modest
but signiﬁcantly greater likelihood of reporting washing
(AOR 1.35; 95% CI 1.22–1.50, Chi-square P\0.0001),
wiping (AOR 1.14; 95% CI 1.05–1.24, Chi-square
P = 0.002) or use of soap and water (AOR 1.23; 95% CI
1.07–1.41, Chi-square P = 0.003) among women in the
intervention group compared to those in the control group.
Therewasnodifferencebystudygroupininsertionpractices
or in use of water (alone) or other products in the vagina.
We further explored the change in vaginal practices over
time: all three decreased with time in the study and the time
effect was signiﬁcant (Chi-square P\0.0001) for each
vaginal practice overall, and within each study group (see
Fig. 1a, b). Furthermore, as shown by the study group by
visit interaction term (Fig. 1b), the rate of decrease over
time in vaginal washing was signiﬁcantly less in the
intervention group compared with the control group
(Chi-square P = 0.0004). The rate of decrease for wiping
was marginally less in the intervention group compared
with the control group (Chi-square P = 0.05). The study
group effect was not observed for vaginal insertion.
Vaginal Practices and Use of Study Methods During
Follow-Up
Of the total 27,469 persons-visits during the follow-up
period, 25,905 (94.3%) were intervals where women were
sexually active, and thus, were included in the examination
of the association between vaginal practices and consistent
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123use of study methods. The association between vaginal
practices and consistent use of diaphragm/gel was exam-
ined among women in the intervention arm only
(n = 2438), for a total of 12,853 persons-visits. During
their time in the study, women reported always using
diaphragms in the previous 3 months at 58.1% of all fol-
low-up visits (with visit-speciﬁc proportions ranging from
54.5 to 61.8%) and reported always using gel at 59.5% of
all follow-up visits (with visit-speciﬁc proportions ranging
from 56.0 to 62.2%). Reports of consistent diaphragm and
gel use (always using both in the previous 3 months) were
reported at 52.2% of follow-up visits (with visit-speciﬁc
proportions ranging from 48.1 to 55.0%). As shown in
Table 3, baseline vaginal practices were not associated
with consistent use of the diaphragm and gel during follow-
up. However, in multivariable analysis, follow-up reports
of washing (AOR 0.88; 95% CI 0.79–0.98), wiping (AOR
0.90; 95% CI 0.83–0.97), and insertion (AOR 0.83; 95% CI
0.74–0.93), were all independently and inversely associ-
ated with consistent use of the diaphragm and gel during
the same time intervals, after controlling for signiﬁcant
confounding baseline variables (study site, age, educational
status, women’s behavioral risk, high risk partner).
Similarly, we examined the association between vaginal
practices and consistent male condom use in the complete
study sample. During their time in the study, women
reported always using condoms in the previous 3 months at
60.7% of all follow-up visits (with visit-speciﬁc propor-
tions ranging from 59.8 to 61.9%); 59.08% (range 58.1–
60.6%) in the intervention group and 62.3% (range 61.0–
3.2%) in the control group (OR 0.87; 95% CI 0.80–0.95).
As shown in Table 4, baseline washing, wiping and spe-
ciﬁc vaginal product use, were signiﬁcantly associated with
a lower likelihood of consistent use of male condoms
Table 2 Vaginal practices and product used (at baseline and follow-up) among MIRA participants, overall and by study group
Baseline Overall Intervention group Control group Chi-square
P value
n = 4925 % n = 2466 % n = 2459 %
Intravaginal washing 4077 82.78 2053 83.25 2024 82.31 ns
Intravaginal wiping 2782 56.49 1417 57.46 1365 55.51 ns
Intravaginal insertion 1013 20.57 516 20.92 497 20.21 ns
Used product in vagina 2608 52.95 1305 52.92 1303 52.99 ns
Water only 1439 29.22 715 28.99 724 29.44 ns
Soap and water 1625 32.99 816 33.09 809 32.90 ns
Other products 269 5.46 138 5.60 131 5.33 ns
Follow-up
persons-visits (pv) n = 27469
pv
%p v n = 13575
pv
%p v n = 13894
pv
% pv OR (95%CI)
a Chi-square
P-value
Intravaginal washing 20821 75.8 10648 78.44 10173 73.22 1.35 (1.22–1.50) \0.0001
Intravaginal wiping 11247 40.94 5772 42.52 5475 39.41 1.14 (1.05–1.24) 0.0019
Intravaginal insertion 3613 13.15 1708 12.58 1905 13.71 0.93 (0.82–1.04) ns
Women’s last visit
b n = 4711 % n = 2353 % n = 2358 % OR (95%CI)
c
Used product in vagina 2192 46.53 1090 46.32 1102 46.73 0.98 (0.88–1.1) ns
Water only 1220 25.9 620 26.35 600 25.45 1.05 (0.92–1.2) ns
Soap and water 1277 27.11 679 28.86 598 25.36 1.23 (1.07–1.41) 0.003
Other products 198 4.2 95 4.04 103 4.37 0.92 (0.69–1.23) ns
All three vaginal practices and use of product in the vagina were asked for the past 3 months (at baseline) or since last quarterly interview (at
follow-up visit)
Other products included at baseline: commercial cleaning product (n = 95; 1.9%); lubricants (n = 57; 1.2%); natural agents (n = 46; 0.9%);
vinegar (n = 43; 0.9%), douche (n = 18; 0.4%), and other unspeciﬁed products (n = 46; 0.9%)
Other products included at last visit: commercial cleaning product (n = 46; 0.9%); lubricants (n = 36; 0.8%); natural agents (n = 28; 0.6%);
vinegar (n = 52; 1.1%), douche (n = 23; 0.5%), and other unspeciﬁed products (n = 40; 0.9%)
OR odds ratio intervention versus control arm, controlling for site, CI conﬁdence interval, ns non-signiﬁcant, pv persons-visits
a GEE
b This question was assessed at participant’s exit visit or last available study visit, in a subset of 4,711 women
c logisitic regression
AIDS Behav (2010) 14:590–599 595
123during follow-up. In multivariable analyses, only baseline
use of vaginal products remained signiﬁcant (AOR 0.90;
95% CI 0.82–0.98). Additionally, follow-up reports of
washing (AOR 0.88; 95% CI 0.82–0.94), wiping (AOR
0.94; 95% CI 0.89–0.99), and insertion (AOR 0.89; 95% CI
0.82–0.97), were all independently and inversely associ-
ated with consistent use of male condoms during follow-
up, after controlling for signiﬁcant confounding baseline
variables (study group, study site, age, marital and educa-
tional status, women’s behavioral risk, high risk partner,
cohabitation, positive curable STI at baseline).
Discussion
We report high prevalence of vaginal practices among
women who participated in MIRA, a multisite HIV preven-
tion trial of the diaphragm used with lubricant gel. Baseline
prevalence was higher than in other studies conducted in
similargeographicalareas(29%inSouthAfrica[21];66%in
ZimbabweandUganda[22]).Thismayresultfromtheuseof
different question types to assess vaginal practices; or from
interview mode, as ACASI has been shown to increase self-
reporting of these socially sensitive behaviors [23].
Odds Ratio
(95% CI)
Chi-square 
p-value
Odds Ratio
(95% CI)
Chi-square 
p-value
.95(.94-.97) p < .0001
.87 (.86-.89) p < .0001
.92 (.91-.94) p < .0001
1.01 (.98-1.03)
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Fig. 1 a Percent women reporting speciﬁc vaginal practices over time
and by study group proportion of women within each study group,
reporting ‘‘ever’’ engaging in a speciﬁed vaginal practice at every
quarterly visit. Visit number: Baseline = 1, 3-month follow-up
visit = 3, 6-month visit = 4, 9-month visit = 5, etc. b Linear trend
test for speciﬁc vaginal practices, by study group study arm-speciﬁc:
within-group linear trend tests for the three vaginal practices,
controlling for repeated measures (with GEE) and study site. Odds
ratio indicates odds of ‘‘ever’’ engaging in speciﬁed vaginal practice at
one visit compared to previous visit. Vaginal practices (washing,
wiping and insertion) were measured at baseline and every quarterly
visit.StudyArmbyvisitinteraction:foreachspeciﬁedvaginalpractice,
odds ratio of study arm by visit interaction term (with intervention
group as reference category). 95% CI 95% conﬁdence interval
Table 3 Univariate and multivariate models of the association between speciﬁc vaginal practices at baseline and follow-up, and consistent
diaphragm/gel use among MIRA Intervention Group participants (2,438 participants; 12,853 persons-visits)
Vaginal practices Univariate analyses Multivariate analyses
OR
estimate
Lower
95% CI
Upper
95% CI
Chi-square
P-value
AOR
estimate
Lower
95% CI
Upper 95%
CI
Chi-square
P-value
Baseline measures
Baseline intravaginal washing 0.92 0.79 1.08 ns na
Baseline intravaginal wiping 0.99 0.88 1.12 ns na
Baseline intravaginal insertion 1.12 0.97 1.29 ns na
Baseline used product in vagina* 0.91 0.81 1.03 ns na
Repeated-measures at follow up
Intravaginal washing at follow-up* 0.83 0.76 0.92 0.0003 0.88 0.79 0.98 0.0147
Intravaginal wiping at follow-up
a 0.86 0.80 0.93 \0.0001 0.90 0.83 0.97 0.0083
Intravaginal insertion at follow-up
a 0.80 0.72 0.90 \0.0001 0.83 0.74 0.93 0.0014
a In univariate analyses, washing, wiping and insertion at follow-up visits were controlled for at study site
Multivariate analyses controlled for baseline factors and potential confounders that remained signiﬁcant at P\0.05: study site, age, educational
status, women’s behavioral risk, high risk partner
OR odds ratio, AOR adjusted OR, CI conﬁdence interval, na not applicable, ns non signiﬁcant
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123Standardized counseling in MIRA discouraged vaginal
practices or use of non-study vaginal products for all par-
ticipants. It is thus plausible that these practices reportedly
decreased during the trial because of the counseling women
received or because of social desirability bias. Of note,
washing decreased the least, while vaginal insertion
decreased the most, suggesting that certain practices may
be less amenable to change than others. Speciﬁcally, local
norms about women’s genital hygiene place great value on
‘‘vaginal cleanliness’’ and excessive vaginal secretion and/
or post-coital discharges are viewed as ‘‘dirty’’ [4, 5, 7, 24,
25]. Furthermore, keeping the vagina clean and removing
undesirable discharge are not just motivated by hygiene but
also by local views of sexuality, such as the expectation
that women maintain their vagina in a ‘‘virgin-like state’’
by removing any evidence of prior sexual activity, to sat-
isfy the sexual needs of the male partner and to ensure his
ﬁdelity [6]. Thus, daily vaginal washing as well as post-
coital washing may be more likely to persist despite
repeated counseling.
Women in the intervention group, who received dia-
phragm, gel and condoms, had a greater likelihood of
reporting vaginal practices during follow-up compared to
those in the control group, who received condoms only.
This occurred despite the fact that overall, reported prac-
tices decreased over time in both groups. Manual insertion
and removal of the diaphragm could have encouraged more
frequent vaginal practices, such as ﬁnger cleansing.
Also gel may add to the amount of post-coital discharge,
and increase the likelihood of vaginal cleaning after
sex. Alternatively, given that in MIRA, the study gel was
generally liked and was believed to have ‘‘cleansing’’ prop-
erties [16] (Sahin-Hoduglugil, personal communication,
August 2009), participants may have used it as a cleans-
ing tool. Further research should aim to better understand
women’s motivations for vaginal practices and to tease
out these possible alternative explanations. Of note, local
beliefs and perceptions about beneﬁcial and cleansing
properties of a potential microbicide were also reported in
a study of South African sex workers [26] and in a large
microbicide trial [27]. Thus, while studies have shown
that some level of lubrication during sex is welcomed, and
that lubricant and microbicide acceptability is generally
high in settings where vaginal practices are prevalent [28–
30], it is possible that gel use may sustain or increase
certain vaginal practices. In contrast, use of male condoms
should prevent any post-coital discharge, and hence, this
may in part explain lower vaginal practices reported in the
control group. Condoms were equally promoted in both
groups, but reported use was lower in the intervention
group [15].
Our ﬁndings also indicate that vaginal practices were
associated with a lower likelihood of consistently using the
investigational products (diaphragm and gel) among
women in the intervention group, as well as a lower like-
lihood of consistently using condoms, overall. Although
the effects were small, the associations were independently
associated with all three vaginal practices examined, and
cumulatively may add up to a substantial effect, specially,
given that most women reported more than one type of
practice. Only baseline use of vaginal products was inde-
pendently associated with a lower likelihood of consistent
condom use, suggesting a potential causal relationship. All
other associations between vaginal practices and methods
use were concurrently assessed during follow-up, and thus
could be correlated without being causally related. Of note,
Table 4 Univariate and multivariate models of the association between speciﬁc vaginal practices at baseline and follow-up, and consistent
condom use among MIRA participants (both study groups combined) (4874 participants, 25,905 persons-visits)
Vaginal practices Univariate analyses Multivariate analyses
OR
estimate
Lower
95% CI
Upper
95% CI
Chi-square
P-value
AOR
estimate
Lower
95% CI
Upper
95% CI
Chi-square
P-value
Baseline measures
Baseline intravaginal washing 0.89 0.79 0.99 0.033 na
Baseline intravaginal wiping 0.84 0.77 0.91 \.0001 na
Baseline intravaginal insertion 0.91 0.82 1.01 ns na
Baseline used product in vagina
a 0.88 0.81 0.97 0.0064 0.90 0.82 0.98 0.021
Repeated-measures at follow up
Intravaginal washing at follow-up
a 0.83 0.78 0.89 \.0001 0.88 0.82 0.94 0.0002
Intravaginal wiping at follow-up
a 0.89 0.85 0.94 \.0001 0.94 0.89 0.99 0.0327
Intravaginal insertion at follow-up
a 0.86 0.80 0.93 0.0002 0.89 0.82 0.97 0.0067
a In univariate analyses, washing, wiping and insertion at follow-up visits were controlled for at study site
Multivariate analyses controlled for baseline factors and potential confounders that remained signiﬁcant at P\0.05: study group, study site, age,
married, educational status, women’s behavioral risk, high risk partner, cohabitation, postive curable STI at baseline
OR odds ratio, AOR adjusted OR, CI conﬁdence interval, na not applicable, ns non signiﬁcant
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123small exploratory studies in Zimbabwe and Kenya reported
that some vaginal practices may interfere with correct or
consistent use of the diaphragm [31, 32]. We also found
that vaginal wiping was associated with lower diaphragm
insertion skills in this study population [33].
Several other qualitative studies have indicated that
vaginal practices may interfere with use and effectiveness
of condoms [6, 34, 35]. Use of condoms may conﬂict with
sexual norms favoring the exchange of ﬂuids and positive
sensations of heat caused by ‘‘skin to skin’’ friction during
sex. Also the effects of intravaginal agents used for tight-
ening, warming or improving the sexual experience may
not be felt across a physical barrier. For example, in a
qualitative study in Zimbabwe, some women were reluc-
tant to use condoms for fear of blocking the ‘magic’ of
drying agents [5]. However this study is amongst the ﬁrst to
quantitatively show in a large sample of women that such
associations exist.
Thereareseverallimitationstothisstudy:ﬁrst,wedidnot
use standardized measures of vaginal practices nor did we
have detailed measures, including when these vaginal
practices took place in relation to sex or to use of study
methods [4]. Measures of vaginal practices and of study
methodusewereself-reportedandthus,susceptibletosocial
desirability bias. However, this would make women reluc-
tant to report both vaginal practices and inconsistent study
method use, decreasing the likelihood of ﬁnding an associ-
ation between the two. Also, because we had no a priori
reason to expect differential reports of vaginal practices by
studyarm,ouranalysisofdifferencesinvaginalpracticesby
randomization group should be quite robust.
There is an urgent need to establish which vaginal prac-
tices are harmful to women’s health and which are not.
Recently a Vaginal Practice Research Partnership (VPRP)
was created to investigate evidence about the hypothesized
causal pathway between women’s vaginal practices and
acquisition of HIV infection. The Partnership is conducting
an individual patient data (IPD) meta-analysis of studies
identiﬁed in a systematic review of the research literature,
and preliminary data from nine cohort studies (including
MIRA) suggest an increased risk of HIV associated with
certain vaginal practices, particularly practices other than
cleansing with water [36]. Another way vaginal practices
could be harmful is if they interfere with HIV prevention
practices. Here, we report an inverse relationship between
vaginal practices and consistent use of HIV prevention
methods evaluated in the MIRA trial. Although these are
potentiallymodiﬁablebehaviors,changingvaginalpractices
may not be straightforward given their cultural and social
meanings. Still, by better understanding the motivations and
needs behind these practices, it may be possible to educate
women, and suggest healthy alternatives that can fulﬁll
underlyingmotivations.Forexample,anecdotalinformation
in Zimbabwe indicated that mint ﬂavored condoms (who
provided a refreshing and tingling sensation) could be
substituted for vaginal insertion of Vicks, a mint-based
commercial product [5]. In MIRA, participants and their
partners were provided with standard and ﬂavored condoms
(i.e. mint, strawberry, banana, chocolate), and these ﬂavor-
ing additives appeared to make condom use more likeable
(H.Cheng,personalcommunication,November2009).Also
most women reportedly ‘‘prepare for sex’’ by washing their
genitaliadaily [7].Researchers couldcapitalize on thishabit
to suggest daily insertion of a microbicide to ‘‘prepare for
sex’’,especiallyifitsformulationinducesvaginalsensations
of cleanliness and freshness, as reported with some gels [27,
37, 38]. Finally, as discussed above, the perceived ‘‘cleans-
ing’’ properties of investigational gels, could serve to
encourage gel insertion and discourage early removal or co-
insertion of other substances.
In summary, future studies should help distinguish
‘‘harmful’’ vaginal practices from ‘‘harmless’’ ones, and
their potential effects on microbicides and other vaginal
methods’ acceptability, effectiveness and safety. Further
research on the meaning and motivation of these practices
could inform the development of improved educational
strategies to address these modiﬁable behaviors in the
context of HIV prevention interventions, to maximize
consistent and correct vaginal method use and minimize
potential interference by existing vaginal practices.
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